Caldwell Sutter Capital’s Boston Scientific BSX Stock Holding History

Caldwell Sutter Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.41K	Hold	80	–	–	﹤0.01%	743
2026 Q1	$5.02K	Hold	80	–	–	﹤0.01%	645
2025 Q4	$7.63K	Hold	80	–	–	﹤0.01%	585
2025 Q3	$7.81K	Hold	80	–	–	﹤0.01%	587
2025 Q2	$8.59K	Hold	80	–	–	﹤0.01%	555
2025 Q1	$8.07K	Sell	80 -20	-20%	-$2.01K	﹤0.01%	569
2024 Q4	$8.93K	Hold	100	–	–	﹤0.01%	565
2024 Q3	$8.38K	Hold	100	–	–	﹤0.01%	578
2024 Q2	$7.7K	Sell	100 -70	-41%	-$5.12K	﹤0.01%	583
2024 Q1	$11.6K	Hold	170	–	–	0.01%	526
2023 Q4	$9.83K	Sell	170 -30	-15%	-$1.6K	0.01%	550
2023 Q3	$10.6K	Hold	200	–	–	0.01%	521
2023 Q2	$10.8K	Hold	200	–	–	0.01%	516
2023 Q1	$10K	Buy	+200	New	+$9.43K	0.01%	388

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caldwell Sutter Capital's BSX Position: Q2 2026 in Review

Caldwell Sutter Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 80 shares worth $3.41K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Caldwell Sutter Capital first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.6K in Q1 2024. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Caldwell Sutter Capital held 80 shares of Boston Scientific worth $3.41K as of Q2 2026.
Caldwell Sutter Capital left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #743 holding.
Caldwell Sutter Capital first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
Caldwell Sutter Capital's Boston Scientific position peaked at $11.6K in Q1 2024.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.